Latvia Pharmaceuticals & Healthcare Q4 2018
Cost-containment will remain a prominent theme within the Latvian pharmaceutical market, repressing drugmaker salesgrowth. With the introduction of a mandatory social health insurance system in 2019, these pressures will increase, offsetting thepositive impact of increased access to services and a reduction in out-of-pocket payments. As a result the small market will fail toprovide lucrative revenue growth opportunities relative to the majority of its EU counterparts.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook